Skip to main content

Infections in Patients with Malignant Lymphomas

  • Chapter
  • First Online:
  • 1550 Accesses

Abstract

Malignant lymphomas are among the most common hematologic malignancies in man and are associated with substantial morbidity and mortality. Infections in patients with malignant lymphomas are relatively frequent as a result of multiple immunologic deficits caused by the underlying malignancy and various treatment modalities. The spectrum of infection in this group of patients is much broader than in patients in whom neutropenia is the predominant predisposing factor, with bacterial, mycobacterial, fungal, viral and parasitic organisms – all being important. A specific diagnosis of infection is sometimes difficult to establish. On the other hand, multiple infections may be present in the same patient as the same time, or may follow each other sequentially. Consequently, infection prevention strategies play an important role in these patients.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.

    Article  PubMed  Google Scholar 

  2. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966;64(2):328–40.

    Article  CAS  PubMed  Google Scholar 

  3. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011;52(4):e56–93.

    Article  PubMed  Google Scholar 

  4. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis. 2003;36(9):1103–10.

    Article  PubMed  Google Scholar 

  5. Shelburne SA, Tarrand J, Rolston KV. Review of streptococcal bloodstream infections at a comprehensive cancer care center, 2000–2011. J Infect. 2013;66(2):136–46.

    Article  PubMed  Google Scholar 

  6. Kumashi P, Girgawy E, Tarrand JJ, Rolston KV, Raad II, Safdar A. Streptococcus pneumoniae bacteremia in patients with cancer: disease characteristics and outcomes in the era of escalating drug resistance (1998–2002). Medicine (Baltimore). 2005;84(5):303–12.

    Article  Google Scholar 

  7. Mitchell R, Trück J, Pollard AJ. Use of the 13-valent pneumococcal conjugate vaccine in children and adolescents aged 6–17 years. Expert Opin Biol Ther. 2013;13:1451–65.

    Article  CAS  PubMed  Google Scholar 

  8. Torres HA, Reddy BT, Raad II, et al. Nocardiosis in cancer patients. Medicine (Baltimore). 2002;81(5):388–97.

    Article  CAS  Google Scholar 

  9. Sakai C, Takagi T, Satoh Y. Nocardia asteroides pneumonia, subcutaneous abscess and meningitis in a patient with advanced malignant lymphoma: successful treatment based on in vitro antimicrobial susceptibility. Intern Med. 1999;38(8):683–6.

    Article  CAS  PubMed  Google Scholar 

  10. Enomoto M, Yamasawa H, Sawai T, Bando M, Ohno S, Sugiyama Y. Pulmonary nocardiosis with bilateral diffuse granular lung shadows in a patient with subcutaneous panniculitic T-cell lymphoma. Intern Med. 2002;41(11):986–9.

    Article  PubMed  Google Scholar 

  11. Gradel KO, Nørgaard M, Dethlefsen C, et al. Increased risk of zoonotic Salmonella and Campylobacter gastroenteritis in patients with haematological malignancies: a population-based study. Ann Hematol. 2009;88(8):761–7.

    Article  PubMed  Google Scholar 

  12. Li CW, Chen PL, Lee NY, et al. Non-typhoidal Salmonella bacteremia among adults: an adverse prognosis in patients with malignancy. J Microbiol Immunol Infect. 2012;45(5):343–9.

    Article  PubMed  Google Scholar 

  13. Beyazit Y, Guven GS, Kocak T, Kekilli M. Salmonella meningitis in an adult patient with central nervous system lymphoma. Eur J Intern Med. 2005;16(5):377–8.

    Article  PubMed  Google Scholar 

  14. Pacanowski J, Lalande V, Lacombe K, et al. Campylobacter bacteremia: clinical features and factors associated with fatal outcome. Clin Infect Dis. 2008;47(6):790–6.

    Article  PubMed  Google Scholar 

  15. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005;366(9497):1653–66.

    Article  CAS  PubMed  Google Scholar 

  16. Sejvar JJ, Kohl KS, Gidudu J, et al. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29(3):599–612.

    Article  PubMed  Google Scholar 

  17. Mencacci A, Corbucci C, Castellani A, Furno P, Bistoni F, Vecchiarelli A. Legionella pneumophila serogroup 3 pneumonia in a patient with low-grade 4 non-Hodgkin lymphoma: a case report. J Med Case Rep. 2011;5:387.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Leoni E, De Luca G, Legnani PP, Sacchetti R, Stampi S, Zanetti F. Legionella waterline colonization: detection of Legionella species in domestic, hotel and hospital hot water systems. J Appl Microbiol. 2005;98(2):373–9.

    Article  CAS  PubMed  Google Scholar 

  19. Liu WK, Healing DE, Yeomans JT, Elliott TS. Monitoring of hospital water supplies for Legionella. J Hosp Infect. 1993;24(1):1–9.

    Article  CAS  PubMed  Google Scholar 

  20. Miyara T, Tokashiki K, Shimoji T, Tamaki K, Koide M, Saito A. Rapidly expanding lung abscess caused by Legionella pneumophila in immunocompromised patients: a report of two cases. Intern Med. 2002;41(2):133–7.

    Article  PubMed  Google Scholar 

  21. Singh J, Batish VK, Grover S. Simultaneous detection of Listeria monocytogenes and Salmonella spp. in dairy products using real time PCR-melt curve analysis. J Food Sci Technol. 2012;49(2):234–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Pricope-Ciolacu L, Nicolau AI, Wagner M, Rychli K. The effect of milk components and storage conditions on the virulence of Listeria monocytogenes as determined by a Caco-2 cell assay. Int J Food Microbiol. 2013;166(1):59–64.

    Article  CAS  PubMed  Google Scholar 

  23. Rivero GA, Torres HA, Rolston KV, Kontoyiannis DP. Listeria monocytogenes infection in patients with cancer. Diagn Microbiol Infect Dis. 2003;47(2):393–8.

    Article  CAS  PubMed  Google Scholar 

  24. Martino R, Rámila E, Capdevila JA, et al. Bacteremia caused by Capnocytophaga species in patients with neutropenia and cancer: results of a multicenter study. Clin Infect Dis. 2001;33(4):E20–2.

    Article  CAS  PubMed  Google Scholar 

  25. Dannenberg AM. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol Today. 1991;12(7):228–33.

    Article  PubMed  Google Scholar 

  26. Karakas Z, Agaoglu L, Taravari B, et al. Pulmonary tuberculosis in children with Hodgkin’s lymphoma. Hematol J. 2003;4(1):78–81.

    Article  PubMed  Google Scholar 

  27. Costa LJ, Gallafrio CT, França FO, del Giglio A. Simultaneous occurrence of Hodgkin disease and tuberculosis: report of three cases. South Med J. 2004;97(7):696–8.

    Article  PubMed  Google Scholar 

  28. Melero M, Gennaro O, Domínguez C, Sánchez Avalos JC. Tuberculosis in patients with lymphomas. Medicina (B Aires). 1992;52(4):291–5.

    CAS  Google Scholar 

  29. Codrich D, Monai M, Pelizzo G, et al. Primary pulmonary Hodgkin’s disease and tuberculosis in an 11-year-old boy: case report and review of the literature. Pediatr Pulmonol. 2006;41(7):694–8.

    Article  PubMed  Google Scholar 

  30. Chen CY, Sheng WH, Lai CC, et al. Mycobacterial infections in adult patients with hematological malignancy. Eur J Clin Microbiol Infect Dis. 2012;31(6):1059–66.

    Article  PubMed  Google Scholar 

  31. Wei MC, Banaei N, Yakrus MA, Stoll T, Gutierrez KM, Agarwal R. Nontuberculous mycobacteria infections in immunocompromised patients: single institution experience. J Pediatr Hematol Oncol. 2009;31(8):556–60.

    Article  PubMed  Google Scholar 

  32. Gupta S, Cogbill CH, Gheorghe G, et al. Mycobacterium avium intracellulare infection coexistent with nodular lymphocyte predominant Hodgkin lymphoma involving the lung. J Pediatr Hematol Oncol. 2011;33(3):e127–31.

    Article  PubMed  Google Scholar 

  33. Han XY, Tarrand JJ, Infante R, Jacobson KL, Truong M. Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare among patients without AIDS. J Clin Microbiol. 2005;43(9):4407–12.

    Article  PubMed Central  PubMed  Google Scholar 

  34. World Health Organization, Stop TB Initiative (World Health Organization). Treatment of tuberculosis: guidelines. 4th ed. Geneva: World Health Organization; 2010.

    Google Scholar 

  35. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167(4):603–62.

    Article  PubMed  Google Scholar 

  36. Obeid KM, Aguilar J, Szpunar S, et al. Risk factors for Pneumocystis jirovecii pneumonia in patients with lymphoproliferative disorders. Clin Lymphoma Myeloma Leuk. 2012;12(1):66–9.

    Article  PubMed  Google Scholar 

  37. Kumar N, Bazari F, Rhodes A, Chua F, Tinwell B. Chronic Pneumocystis jiroveci presenting as asymptomatic granulomatous pulmonary nodules in lymphoma. J Infect. 2011;62(6):484–6.

    Article  PubMed  Google Scholar 

  38. Kamel S, O’Connor S, Lee N, Filshie R, Nandurkar H, Tam CS. High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone. Leuk Lymphoma. 2010;51(5):797–801.

    Article  CAS  PubMed  Google Scholar 

  39. Tadmor T, McLaughlin P, Polliack A. A resurgence of Pneumocystis in aggressive lymphoma treated with R-CHOP-14: the price of a dose-dense regimen? Leuk Lymphoma. 2010;51(5):737–8.

    Article  PubMed  Google Scholar 

  40. Hardak E, Oren I, Dann EJ, et al. The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experience. Acta Haematol. 2012;127(2):110–4.

    Article  CAS  PubMed  Google Scholar 

  41. Rolston KV. Editorial commentary: Cryptococcosis due to Cryptococcus gattii. Clin Infect Dis. 2013;57(4):552–4.

    Article  PubMed  Google Scholar 

  42. Kontoyiannis DP, Peitsch WK, Reddy BT, et al. Cryptococcosis in patients with cancer. Clin Infect Dis. 2001;32(11):E145–50.

    Article  CAS  PubMed  Google Scholar 

  43. Hirai Y, Ainoda Y, Shoji T, et al. Disseminated cryptococcosis in a non-Hodgkin’s lymphoma patient with late-onset neutropenia following rituximab-CHOP chemotherapy: a case report and literature review. Mycopathologia. 2011;172(3):227–32.

    Article  PubMed  Google Scholar 

  44. Marchand T, Revest M, Tattevin P, et al. Early cryptococcal meningitis following treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia. Leuk Lymphoma. 2013;54(3):643–5.

    Article  CAS  PubMed  Google Scholar 

  45. Slavin MA, Chen SC. Cryptococcosis, lymphoproliferative disorders and modern day chemotherapy regimens. Leuk Lymphoma. 2013;54(3):449–50.

    Article  PubMed  Google Scholar 

  46. Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2010;50(3):291–322.

    Article  PubMed  Google Scholar 

  47. Jones O, Cleveland KO, Gelfand MS. A case of disseminated histoplasmosis following autologous stem cell transplantation for Hodgkin’s lymphoma: an initial misdiagnosis with a false-positive serum galactomannan assay. Transpl Infect Dis. 2009;11(3):281–3.

    Article  CAS  PubMed  Google Scholar 

  48. Hill D, Dubey JP. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect. 2002;8(10):634–40.

    Article  CAS  PubMed  Google Scholar 

  49. de Medeiros BC, de Medeiros CR, Werner B, et al. Central nervous system infections following bone marrow transplantation: an autopsy report of 27 cases. J Hematother Stem Cell Res. 2000;9(4):535–40.

    Article  PubMed  Google Scholar 

  50. Maschke M, Dietrich U, Prumbaum M, et al. Opportunistic CNS infection after bone marrow transplantation. Bone Marrow Transplant. 1999;23(11):1167–76.

    Article  CAS  PubMed  Google Scholar 

  51. Mele A, Paterson PJ, Prentice HG, Leoni P, Kibbler CC. Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant. 2002;29(8):691–8.

    Article  CAS  PubMed  Google Scholar 

  52. Singh N, Husain S. Infections of the central nervous system in transplant recipients. Transpl Infect Dis. 2000;2(3):101–11.

    Article  CAS  PubMed  Google Scholar 

  53. Pagano L, Trapè G, Putzulu R, et al. Toxoplasma gondii infection in patients with hematological malignancies. Ann Hematol. 2004;83(9):592–5.

    Article  PubMed  Google Scholar 

  54. Marcos LA, Terashima A, Dupont HL, Gotuzzo E. Strongyloides hyperinfection syndrome: an emerging global infectious disease. Trans R Soc Trop Med Hyg. 2008;102(4):314–8.

    Article  PubMed  Google Scholar 

  55. Concha R, Harrington W, Rogers AI. Intestinal strongyloidiasis: recognition, management, and determinants of outcome. J Clin Gastroenterol. 2005;39(3):203–11.

    Article  PubMed  Google Scholar 

  56. Win TT, Sitiasma H, Zeehaida M. Strongyloides stercoralis induced bilateral blood stained pleural effusion in patient with recurrent non-Hodgkin lymphoma. Trop Biomed. 2011;28(1):64–7.

    CAS  PubMed  Google Scholar 

  57. Krause PJ, Gewurz BE, Hill D, et al. Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis. 2008;46(3):370–6.

    Article  PubMed  Google Scholar 

  58. Cunha BA. Central nervous system infections in the compromised host: a diagnostic approach. Infect Dis Clin N Am. 2001;15(2):567–90.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenneth V. I. Rolston .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Rolston, K.V.I. (2015). Infections in Patients with Malignant Lymphomas. In: Maschmeyer, G., Rolston, K. (eds) Infections in Hematology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44000-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-44000-1_2

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-43999-9

  • Online ISBN: 978-3-662-44000-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics